Mitsubishi UFJ Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$217K Sell
23,270
-575
-2% -$5K ﹤0.01% 961
2025
Q4
$175K Buy
+23,845
New +$242K ﹤0.01% 1039
2025
Q2
Sell
-30,605
Closed -$98.9K 1627
2025
Q1
$98.9K Buy
30,605
+2,564
+9% +$12.1K ﹤0.01% 1027
2024
Q4
$166K Buy
28,041
+17,576
+168% +$138K ﹤0.01% 1017
2024
Q3
$113K Sell
10,465
-983
-9% -$16.3K ﹤0.01% 1018
2024
Q2
$240K Sell
11,448
-7,519
-40% -$189K ﹤0.01% 943
2024
Q1
$604K Sell
18,967
-868
-4% -$22.1K ﹤0.01% 852
2023
Q4
$400K Buy
19,835
+4,557
+30% +$60K ﹤0.01% 945
2023
Q3
$194K Buy
15,278
+820
+6% +$13.7K ﹤0.01% 1025
2023
Q2
$261K Buy
14,458
+2,422
+20% +$44.6K ﹤0.01% 1004
2023
Q1
$207K Hold
12,036
﹤0.01% 1024
2022
Q4
$248K Buy
+12,036
New +$186K ﹤0.01% 1001
2022
Q2
Sell
-13,443
Closed -$203K 1164
2022
Q1
$203K Buy
13,443
+905
+7% +$14.2K ﹤0.01% 1054
2021
Q4
$284K Buy
+12,538
New +$307K ﹤0.01% 1021

Other funds holding FDMT